XBKK
OSP
Market cap1.40bUSD
Nov 12, Last price
15.60THB
Name
Osotspa PCL
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Osotspa Public Company Limited, established in Bangkok, Thailand, in 1891, is a global leader in the manufacturing and distribution of various consumer goods, with a primary focus on energy drinks and personal care items. The company’s extensive operations are structured into three main divisions: Beverage, Personal Care, and Other Services. Its comprehensive beverage portfolio encompasses a wide range of popular brands, including energy drinks like M-150, Lipovitan-D, Chalarm, White Shark, and Shark Energy Drink. This segment also extends to ready-to-drink coffee under the M-Presso label, M-Electrolyte sports beverages, and functional drinks such as Peptein, C-Vitt, and Calpis Lacto. Within the personal care sector, Osotspa offers baby products through its Babi Mild line, male grooming solutions under the Exit brand, and a diverse selection of women's beauty care items, including Twelve Plus and Plantstory. Additionally, this division features healthcare products like KRISNAKLAN and Utaitip, alongside confectionery brands such as Botan and Ole. Beyond its core product lines, Osotspa operates a multifaceted "Other Services" segment. This involves the production and supply of glass, beverage concentrates, and premixes. The company further provides marketing and property rental services, handles the distribution of food, beverages, and cullet, and is active in the import, wholesale, and retail of beverages. Its diverse activities also include investing in other ventures, offering research and development services, operating an e-commerce platform, and facilitating the education and sale of herbal products. Furthermore, Osotspa generates revenue through trademark licensing and provides general manufacturing and distribution services to third parties.
Valuation
Title THB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||